Niisato Y, Moriwaki T, Fukuoka S, Masuishi T, et al. Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment. Anticancer Res 2021;41:2203-2207.
PMID: 33813435